Terms: = Breast cancer AND LASP1, ENSG00000002834, 3927, Q14847, MLN50, Lasp-1
40 results:
1. Proficiency testing of diagnosis in histopathology and immunohistochemistry of breast pathology in China: results from a pilot work of National Single Disease Quality Control Program for breast cancer.
Xue X; Guo L; Guo C; Li L; Yang L; Wang X; Rao W; Yuan P; Mu J; Li J; Wang B; Zhou Q; Yang W; Liu Y; Xue W; Jia R; Yang W; Ying J
BMC Cancer; 2024 Jan; 24(1):23. PubMed ID: 38166768
[TBL] [Abstract] [Full Text] [Related]
2. Long noncoding RNA PPP1R14B-AS1 imitates microRNA-134-3p to facilitate breast cancer progression by upregulating LIM and SH3 protein 1.
Zhou L; Zhang L; Guan X; Dong YI; Liu T
Oncol Res; 2021; 29(4):251-262. PubMed ID: 37303940
[TBL] [Abstract] [Full Text] [Related]
3. Downregulation of long noncoding RNA breast cancer anti-estrogen resistance 4 inhibits cell proliferation, invasion, and migration in esophageal squamous cell carcinoma by regulating the microRNA-181c-5p/LIM and SH3 protein 1 axis.
Ke S; Fang M; Li R; Wang J; Lu J
Bioengineered; 2022 May; 13(5):12998-13010. PubMed ID: 35611706
[TBL] [Abstract] [Full Text] [Related]
4. lasp-1 interacts with ErbB2 in ovarian cancer cells.
Sidhanth C; Bindhya S; Shabna A; Krishnapriya S; Manasa P; Nagare RP; Joshua T; Sneha S; Murhekar K; Ganesan TS
Biochem J; 2022 Jan; 479(1):23-38. PubMed ID: 34881777
[TBL] [Abstract] [Full Text] [Related]
5. Double mutation of APC and BRCA1 in an Italian family.
Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Resse M; Passariello L; Cioffi M; Molinari AM
Cancer Genet; 2020 Jun; 244():32-35. PubMed ID: 32388397
[TBL] [Abstract] [Full Text] [Related]
6. Phosphorylation-Dependent Differences in CXCR4-lasp1-AKT1 Interaction between breast cancer and Chronic Myeloid Leukemia.
Butt E; Stempfle K; Lister L; Wolf F; Kraft M; Herrmann AB; Viciano CP; Weber C; Hochhaus A; Ernst T; Hoffmann C; Zernecke A; Frietsch JJ
Cells; 2020 Feb; 9(2):. PubMed ID: 32075106
[TBL] [Abstract] [Full Text] [Related]
7. New Antiproliferative Cembrane Diterpenes from the Red Sea
Hassan HM; Rateb ME; Hassan MH; Sayed AM; Shabana S; Raslan M; Amin E; Behery FA; Ahmed OM; Bin Muhsinah A; A M Gulder T; Ramadan Abdelmohsen U
Mar Drugs; 2019 Jul; 17(7):. PubMed ID: 31336764
[TBL] [Abstract] [Full Text] [Related]
8. The potential markers of endocrine resistance among HR+ /HER2+ breast cancer patients.
Chen K; Quan J; Yang J; Chen Z
Clin Transl Oncol; 2020 Apr; 22(4):576-584. PubMed ID: 31209793
[TBL] [Abstract] [Full Text] [Related]
9. Mechanism of Telapristone Acetate (CDB4124) on Progesterone Receptor Action in breast cancer Cells.
Davaadelger B; Murphy AR; Clare SE; Lee O; Khan SA; Kim JJ
Endocrinology; 2018 Oct; 159(10):3581-3595. PubMed ID: 30203004
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting lasp1.
Sui Y; Zhang X; Yang H; Wei W; Wang M
Oncol Rep; 2018 Feb; 39(2):473-482. PubMed ID: 29207145
[TBL] [Abstract] [Full Text] [Related]
11. Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231.
Moazzeni H; Najafi A; Khani M
Mol Cell Probes; 2017 Aug; 34():45-52. PubMed ID: 28546132
[TBL] [Abstract] [Full Text] [Related]
12. Proteomic-based investigations on the mode of action of the marine anticancer compound rhizochalinin.
Dyshlovoy SA; Otte K; Venz S; Hauschild J; Junker H; Makarieva TN; Balabanov S; Alsdorf WH; Madanchi R; Honecker F; Bokemeyer C; Stonik VA; von Amsberg G
Proteomics; 2017 Jun; 17(11):. PubMed ID: 28445005
[TBL] [Abstract] [Full Text] [Related]
13. Silencing of LIM and SH3 Protein 1 (lasp-1) Inhibits Thyroid cancer Cell Proliferation and Invasion.
Gao W; Han J
Oncol Res; 2017 Jul; 25(6):879-886. PubMed ID: 27938497
[TBL] [Abstract] [Full Text] [Related]
14. Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (lasp1).
Endres M; Kneitz S; Orth MF; Perera RK; Zernecke A; Butt E
Oncotarget; 2016 Sep; 7(39):64244-64259. PubMed ID: 27588391
[TBL] [Abstract] [Full Text] [Related]
15. lasp-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.
Li Z; Chen Y; Wang X; Zhang H; Zhang Y; Gao Y; Weng M; Wang L; Liang H; Li M; Zhang F; Zhao S; Liu S; Cao Y; Shu Y; Bao R; Zhou J; Liu X; Yan Y; Zhen L; Dong Q; Liu Y
Cancer Lett; 2016 Mar; 372(2):239-50. PubMed ID: 26797416
[TBL] [Abstract] [Full Text] [Related]
16. lasp-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex.
Duvall-Noelle N; Karwandyar A; Richmond A; Raman D
Oncogene; 2016 Mar; 35(9):1122-33. PubMed ID: 25982273
[TBL] [Abstract] [Full Text] [Related]
17. An update on the LIM and SH3 domain protein 1 (lasp1): a versatile structural, signaling, and biomarker protein.
Orth MF; Cazes A; Butt E; Grunewald TG
Oncotarget; 2015 Jan; 6(1):26-42. PubMed ID: 25622104
[TBL] [Abstract] [Full Text] [Related]
18. Profilin-1 overexpression in MDA-MB-231 breast cancer cells is associated with alterations in proteomics biomarkers of cell proliferation, survival, and motility as revealed by global proteomics analyses.
Coumans JV; Gau D; Poljak A; Wasinger V; Roy P; Moens PD
OMICS; 2014 Dec; 18(12):778-91. PubMed ID: 25454514
[TBL] [Abstract] [Full Text] [Related]
19. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (lasp1) in high-risk prostate cancer thereby increasing cell proliferation and migration.
Hailer A; Grunewald TG; Orth M; Reiss C; Kneitz B; Spahn M; Butt E
Oncotarget; 2014 Jun; 5(12):4144-4153. PubMed ID: 24980827
[TBL] [Abstract] [Full Text] [Related]
20. Population-based incidence and patterns of cancer in Kamrup Urban cancer Registry, India.
Sharma JD; Kataki AC; Vijay CR
Natl Med J India; 2013; 26(3):133-41. PubMed ID: 24476158
[TBL] [Abstract] [Full Text] [Related]
[Next]
